Profile
Nature Biotechnology 27, 13 (2009)
doi:10.1038/nbt0109-13
Mark Roth
Charlie Schmidt1
- Portland, Maine
Abstract
Mark Roth's pioneering work on hydrogen sulfide has spawned Ikaria, a company exploring the molecule's potential to modulate the body's metabolism and perhaps one day turn hibernation into profitable clinical applications.


